Caprock Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
17,930
+1,250
+7% +$112K 0.04% 420
2025
Q4
$1.46M Buy
16,680
+6,549
+65% +$497K 0.03% 484
2025
Q3
$621K Buy
+10,131
New +$583K 0.02% 725

Other funds holding GMED

Caprock Group's GMED Position: Q1 2026 in Review

Caprock Group increased its Globus Medical (GMED) stake by 7.5% in Q1 2026, buying an estimated $112K and bringing the position to 17,930 shares worth $1.54M. The position accounts for 0.04% of the portfolio, ranked #420.

Caprock Group first reported a position in GMED in Q3 2025 and has held it in 3 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Caprock Group held 17,930 shares of Globus Medical worth $1.54M as of Q1 2026.
  • Caprock Group bought 1,250 Globus Medical shares in Q1 2026, an estimated $112K.
  • Globus Medical made up 0.04% of Caprock Group's portfolio in Q1 2026, its #420 holding.
  • Caprock Group first reported a position in Globus Medical in Q3 2025 and has held it in 3 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.